Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850926 · ClinicalTrials.gov registry record · NA
Effect of Soccer Head Gear to Reduce Concussions
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 3,050
- Enrollment target
NCT02850926: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT02850926 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 3,050 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (117% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02850926, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,050 participants
- Enrollment target
Study Summary
This study will determine if protective soccer headgear reduces the incidence or severity of Sport Related Concussion injuries (SRCs) in US adolescent (high school) soccer players. Half the subjects will practice and play during their soccer season with soccer head gear specifically marketed to reduce the incidence of SRCs while the other half of the subjects will practice and play without the head gear.
Primary Outcome
To determine if the number of SRC injuries in soccer players wearing HG is lower than soccer players who did not wear head gear (NoHG).
Interventions
- OTHER Soccer head gear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,050 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02850926 record still lists
NCT02850926 is an interventional study that assigns participants to a tested intervention. Its 3,050 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (117% higher).
The record links to 0 conditions, and to 1 intervention - of which Soccer head gear is the first listed.
NCT02850926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02850926 about?
NCT02850926 is a clinical study titled "Effect of Soccer Head Gear to Reduce Concussions". This study will determine if protective soccer headgear reduces the incidence or severity of Sport Related Concussion injuries (SRCs) in US adolescent (high school) soccer players. Half the subjects will practice and play during their soccer season with soccer head gear specifically marketed to redu...
What is the current status of trial NCT02850926?
This trial is currently completed. It is a NA study. The enrollment target is 3,050 participants. The study started on 2016-08. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02850926?
The interventions under investigation include: Soccer head gear (OTHER).
Who is sponsoring clinical trial NCT02850926?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02850926's enrollment target sits among peer trials
3,050 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia